CVE-2024-0758: MolecularFaces · Cross-site Scripting
Affects MolecularFacesSource CVE Database V5
Not known to be exploited · CVSS 6.1 Medium : upgrade to 0.3.0 when convenient.
Data as of 25 Oct 2026, 19:02 UTC
- EPSS
- 0.5% chance of exploitation in 30 days – higher than 46% of CVEsExploit Prediction Scoring System: the likelihood attackers will use this flaw soon.
- Patch
- Available – fixed in 0.3.0
CVSS:3.1/AV:N/AC:L/PR:N/UI:R/S:C/C:L/I:L/A:NExploitation evidence
Disclosed: evidence found.
CVE published 19 Jan 2024
Detectable: no evidence on record.
No public nuclei template indexed
Weaponised: no evidence on record.
No public exploit code indexed in Metasploit or Exploit-DB
Exploited in the wildExploited: no evidence on record.
Not in CISA KEV and no source reports exploitation
Observed by OffSeq MirageSeen by Mirage: no evidence on record.
No attack traffic recorded by OffSeq Mirage sensors
A missing step is not evidence of safety. Sources: cve.org (opens in a new tab), the Metasploit, Exploit-DB and nuclei-templates index as of 2026-10-25.
What to do
Upgrade ipb-halle/MolecularFaces to 0.3.0.
Affected software
| Product | Affected | Fixed in |
|---|---|---|
GitHubipb-halle/MolecularFacespkg:github/ipb-halle/MolecularFacesOther threats | Affected
| Fixed in
|
Check your own hosts for these packages with threat-finder (opens in a new tab), our free open-source scanner.
AI-suggested
If you cannot patch yet, avoid processing untrusted molfiles or implement input validation and sanitization controls where possible to mitigate exploitation risk.
Description
MolecularFaces before 0.3.0 is vulnerable to cross site scripting. A remote attacker can execute arbitrary JavaScript in the context of a victim browser via crafted molfiles.